Dong Y, Saal D, Thomas M, Faust R, Bonci A, Robinson T, Malenka R C
Nancy Pritzker Laboratory, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA 94305, USA.
Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14282-7. doi: 10.1073/pnas.0401553101. Epub 2004 Sep 16.
Synaptic plasticity in the mesolimbic dopamine (DA) system is thought to contribute to the neural adaptations that mediate behavioral sensitization, a model for core aspects of addiction. Recently, it has been demonstrated that multiple classes of drugs of abuse, as well as acute stress, enhance strength at excitatory synapses on midbrain DA neurons. Here, we show that both the cocaine- and stress-induced synaptic enhancement involves an up-regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. This enhancement requires the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor subunit GluRA as evidenced by its absence in mice lacking this subunit. The cocaine-elicited, but not the stress-elicited, synaptic potentiation in DA neurons was blocked by a D1-like receptor antagonist, indicating that the in vivo triggering mechanisms differ for these forms of experience-dependent synaptic modification. Surprisingly, behavioral sensitization to cocaine was elicited in GluRA(-/-) mice, indicating that potentiation of excitatory synaptic transmission in DA neurons is not necessary for this form of behavioral plasticity. However, GluRA(-/-) mice did not exhibit a conditioned locomotor response when placed in a context previously paired with cocaine, nor did they exhibit conditioned place preference in response to cocaine. We suggest that the drug-induced enhancement of excitatory synaptic transmission in midbrain DA neurons, although not required for behavioral sensitization per se, may contribute to the attribution of incentive value to drug-associated cues.
中脑边缘多巴胺(DA)系统中的突触可塑性被认为有助于介导行为敏化的神经适应性变化,行为敏化是成瘾核心方面的一种模型。最近,已经证明多种滥用药物以及急性应激会增强中脑DA神经元兴奋性突触的强度。在此,我们表明可卡因和应激诱导的突触增强都涉及α-氨基-3-羟基-5-甲基-4-异恶唑丙酸受体的上调。这种增强需要α-氨基-3-羟基-5-甲基-4-异恶唑丙酸受体亚基GluRA,缺乏该亚基的小鼠中不存在这种增强现象就证明了这一点。DA神经元中可卡因引发而非应激引发的突触增强被D1样受体拮抗剂阻断,这表明这些形式的经验依赖性突触修饰的体内触发机制不同。令人惊讶的是,GluRA(-/-)小鼠对可卡因产生了行为敏化,这表明DA神经元中兴奋性突触传递的增强对于这种行为可塑性形式并非必要。然而,将GluRA(-/-)小鼠置于先前与可卡因配对的环境中时,它们没有表现出条件性运动反应,对可卡因也没有表现出条件性位置偏好。我们认为,中脑DA神经元中药物诱导的兴奋性突触传递增强,虽然本身对于行为敏化不是必需的,但可能有助于将激励价值归因于与药物相关的线索。